Delivery Order SPE2DB24D8003-SPE2DB25FJTRF
Award Date
1/22/25
Potential Completion Date
1/23/25
Potential Value
$4.3K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,867.25 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of 4,566,689,724 units of the pharmaceutical product DUPIXENT 300 MG/2 ML SYRINGE 2ML. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, valued at $999,999,999.00, which enables the company to provide...
The Defense Logistics Agency (DLA) awarded a $8,232.42 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of DUPIXENT 300 MG/2 ML SYRINGE 2ML. This order was placed under Dakota Drug's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which supports the agency's ECAT Generation V Program for procuring commercial medical equipment, accessories, consumables, and simulation equipment. The contract has an...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The $5,784.90 firm fixed-price contract has a period of performance through January 31, 2025. The contract is not set-aside and is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $4,665.26 contract is for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML pharmaceutical products to support military treatment facilities. This delivery order is issued against Dakota Drug's existing blanket purchase agreement and other contract vehicles...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $13,666.77, is for the provision of DUPIXENT 300 MG/2 ML SYRINGE 2ML pharmaceutical products. This delivery order contract does not have a set-aside designation. Dakota Drug, Inc. specializes in supplying a wide range of prescription medications, vaccines, medical devices, and other...
This is a federal contract award by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,722.06 Firm Fixed Price Delivery Order contract is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The contract has an ultimate completion date of February 5, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML. The order has a completion date of March 4, 2024, and a potential value of $7,091.73. This delivery order is not set aside. Dakota Drug, Inc. has over two decades of experience serving as a prime contractor to the federal government, particularly the Department of...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Dupixent 300 mg/2 ml syringes, a pharmaceutical product used in medical treatment. The contract has a ceiling value of $2,758.88 and a completion date of February 3, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, under the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Dupixent 300 mg/2 ml syringes to support military medical operations. The contract has a ceiling value of $5,495.39 and a performance period extending through January 21, 2025. Dakota Drug, Inc. also holds a larger indefinite delivery contract (IDC) with the DLA, valued at $999,999,999.00, which...
This is a firm fixed-price delivery order awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,627.95 contract is for the supply of the pharmaceutical product DUPIXENT 300 MG/2 ML SYRINGE 2ML. This delivery order is part of the DLA Troop Support Medical's mission to provide comprehensive medical supply chain operations for the U.S. Armed Forces. Dakota Drug, Inc. has a long history of serving as a prime...